🔗 Visit the ClinicalTrials.gov page for NCT00548444
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. | Nat Med | 2004 | 6.46 |
| 2 | Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. | J Clin Invest | 2006 | 3.25 |
| 3 | Rapid turnover of effector-memory CD4(+) T cells in healthy humans. | J Exp Med | 2004 | 1.85 |
| 4 | In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. | Proc Natl Acad Sci U S A | 2007 | 1.36 |
| 5 | Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines. | Hum Vaccin Immunother | 2013 | 0.75 |